Z19.2
Z19.2: Hormone resistant malignancy status
Billable / specific codeICD-10-CMPOA exempt
Z19.2 is a billable, specific ICD-10-CM code for hormone resistant malignancy status. It is valid for submission on a claim.
Check Z19.2 with the rest of the claim: free scrubberInclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Castrate resistant prostate malignancy status
Risk adjustment
No CMS-HCC V28 category: this code does not change a RAF score.
Medicare coverage
Z19.2 is named in 4 Medicare coverage policies: 4 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A58021Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
- A58063Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
- A58183Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
- A58205Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
Alphabetic index entries that lead here
- Status›malignancy›castrate resistant prostate
- Status›malignancy›hormone resistant
Code history
Unchanged in every release from FY2024 to FY2027.